E. Eriksen

Oncology · 2001–2010

A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 20 citations into it; #1,104 of 1,698 by trust here, #543 by citations
• Orthopedics and Sports Medicine — 16 citations into it; #308 of 427 by trust here, #32 by citations
• Molecular Biology — 13 citations into it; #13,095 of 17,773 by trust here, #10,695 by citations

Whom E. Eriksen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Khosla
2. G. Roodman

Who trusts E. Eriksen overall

1. K. Redlich

Papers from E. Eriksen's perspective

Ordered by how strongly the researchers E. Eriksen trusts endorse each paper. Same corpus, a different order for every researcher.

1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (New England Journal of Medicine)
2. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. (Cell)
3. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). (Human Molecular Genetics)
4. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. (Cell Metabolism)
5. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. (Developmental Cell)
6. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (New England Journal of Medicine)
7. Circulating Skeletal Stem Cells (Journal of Cell Biology)
8. Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study * (Journal of Bone and Mineral Research)
9. Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody (Journal of Bone and Mineral Research)
10. Wnt signaling in osteoblasts and bone diseases. (Gene)

Their papers

• Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) — 2,601 citations
• Cellular mechanisms of bone remodeling (2010) — 755 citations
• Zoledronic acid and clinical fractures and mortality after hip fracture. (2007) — 1,826 citations
• Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure (2003) — 605 citations
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (2001) — 4,531 citations